START BREAKING TRADITION
Instead of an ICS/LABA, start appropriate symptomatic patients with COPD on ANORO for dual bronchodilation
ANORO is for the once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
ANORO is NOT for the relief of acute bronchospasm or for asthma.
ANORO was studied in patients with moderate or worse COPD.
ICS/LABA=inhaled corticosteroid/long-acting beta2-adrenergic agonist.